Health Bulletin 26/November/2021

Doctors and Hospitals working under Central Government Health Scheme (CGHS) may soon breathe a sigh of relief, as the Union Health Minister has assured representatives on the revision of the CGHS rates.

Medical Dialogues has repeatedly written about the abysmal rates under the CGHS scheme, the un-viability of which has forced many doctors and hospitals to withdraw from the scheme itself. The rates set in 2014 were Rupees 300 as a indoor consultation and rupees 150 as a outdoor consultation. Not just for consultation, the rates for popular procedures are also very low. Normal delivery is paid Rs 9200 ( to NABH Hospitals) under CGHS which includes all the services of the hospital as well. This is in sharp contrast to Rs 50,000 plus being charged currently in Tier 1 cities from private patients. 

For more details, check out the full story on the link below:

Hospitals Demand Revision Of CGHS Rates, Minister Promises Early Action

Sun Pharmaceutical Industries Ltd has lost a bid to avoid facing a trial over allegations that an Indian drug maker it acquired engaged in an anticompetitive scheme to delay the launch of generic drugs by rivals.

U.S. District Judge Nathaniel Gorton in Boston on Monday ruled Sun failed to compellingly rebut claims by generic drug buyers that they were overcharged for medications as a result of a fraud Ranbaxy Laboratories perpetrated on U.S. regulators.

For more details, check out the full story on the link below:

Sun Pharma To Face Antitrust Trial Over Diovan, Nexium, Valcyte